The advent of highly sensitive troponin assays has shown detectable levels in apparently healthy subjects. Persistently elevated levels (> 99% percentile) can be observed in patients with a variety of chronic diseases, including coronary artery disease (CAD), making the accurate diagnosis of myocardial infarction (MI) challenging.